Procter & Gamble price target lowered to $181 from $186 at JPMorgan

JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Procter & Gamble to $181 from $186 and keeps an Overweight rating on the shares. The firm anticipates an “eventful earnings season” for the household and personal care group, with key debates into 2025 of consumption behavior, impact of currency, tariff risk for multinationals, financial expenses on higher rates for longer, and asset allocation. In light of the new U.S. administration and “many puts and takes” from a macro-political standpoint, JPMorgan expects companies will opt for a “very conservative approach to their outlook.”